WINTON GROUP Ltd - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 150 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$880,000
+10.6%
15,489
-14.4%
0.05%
+14.0%
Q2 2021$796,000
-18.2%
18,091
-8.3%
0.04%
-23.2%
Q1 2021$973,000
+19.4%
19,724
+1.8%
0.06%
-5.1%
Q4 2020$815,000
-59.5%
19,366
-55.9%
0.06%
-9.2%
Q3 2020$2,010,000
-64.2%
43,902
-60.7%
0.06%
-55.2%
Q2 2020$5,612,000
-13.0%
111,769
-10.9%
0.14%
-14.7%
Q1 2020$6,453,000
-24.3%
125,472
-9.1%
0.17%
+41.7%
Q4 2019$8,524,000
+3757.0%
137,980
+3647.4%
0.12%
+3900.0%
Q3 2019$221,000
-57.0%
3,682
-39.6%
0.00%
-70.0%
Q2 2019$514,000
+18.2%
6,095
+33.8%
0.01%
+11.1%
Q1 2019$435,000
+75.4%
4,556
+30.1%
0.01%
+80.0%
Q4 2018$248,000
-38.0%
3,502
-25.1%
0.01%
-37.5%
Q3 2018$400,000
-91.8%
4,677
-88.9%
0.01%
-93.5%
Q2 2018$4,869,000
+1161.4%
42,007
+779.5%
0.12%
+1027.3%
Q1 2018$386,0004,7760.01%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 476,042$45,472,00012.29%
Stonepine Capital Management, LLC 60,840$5,811,0003.34%
ACUTA CAPITAL PARTNERS, LLC 61,000$5,827,0002.77%
Virtus ETF Advisers LLC 10,634$1,016,0002.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 61,000$5,827,0002.15%
ARMISTICE CAPITAL, LLC 372,000$35,533,0001.94%
Matarin Capital Management, LLC 209,403$20,002,0001.46%
Monashee Investment Management LLC 50,000$4,776,0001.10%
Granahan Investment Management 151,322$14,454,0000.78%
ALGERT GLOBAL LLC 13,186$1,260,0000.72%
View complete list of ENANTA PHARMACEUTICALS INC shareholders